• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.60 Up 0.02(0.78%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:2.58
    Open:2.58
    Bid:2.50 x 1100
    Ask:2.70 x 2000
    1y Target Est:11.00
    Beta:1.05
    Next Earnings Date:N/A
    Day's Range:2.53 - 2.71
    52wk Range:2.08 - 8.35
    Volume:387,102
    Avg Vol (3m):776,079
    Market Cap:144.91M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 0.78%144.91M
    LLYUp 0.33%75.29B
    NVSUp 0.20%227.60B
    SNYDown 0.43%121.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,437.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback